Biotransformation of fluorinated drugs and xenobiotics by the model fungus Cunninghamella elegans.

Autor:	Khan MF; UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland., Hof C; UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland., Niemcova P; UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland., Murphy CD; UCD School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland; UCD Conway Institute, University College Dublin, Dublin, Ireland. Electronic address: cormac.d.murphy@ucd.ie.
Jazyk:	angličtina
Zdroj:	Methods in enzymology [Methods Enzymol] 2024; Vol. 696, pp. 251-285. Date of Electronic Publication: 2024 Mar 16.
DOI:	10.1016/bs.mie.2023.12.016
Abstrakt:	Some species of the genus Cunninghamella (C. elegans, C. echinulata and C. blaskesleeana) produce the same phase I and phase II metabolites when incubated with xenobiotics as mammals, and thus are considered microbial models of mammalian metabolism. This had made these fungi attractive for metabolism studies with drugs, pesticides and environmental pollutants. As a substantial proportion of pharmaceuticals and agrochemicals are fluorinated, their biotransformation has been studied in Cunninghamella fungi and C. elegans in particular. This article details the methods employed for cultivating the fungi in planktonic and biofilm cultures, and extraction and analysis of fluorinated metabolites. Furthermore, protocols for the heterologous expression of Cunninghamella cytochromes P450 (CYPs), which are the enzymes associated with phase I metabolism, are described. (Copyright © 2024. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu